Citations

Clear

4093 citation(s) found for "Yu, Jonathan".

Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome
Lahrouchi, Najim , Crotti, Lia , Mizusawa, Yuka , Postema, Pieter G. , Beekman, Leander , Walsh, Roddy , Hasegawa, Kanae , Barc, Julien , Ernsting, Marko, Turkowski, Kari L. , Mazzanti, Andrea , Beckmann, Britt M., Diamant, Ulla‐Britt , Kucho, Yu, Robyns, Tomas , Winbo, Annika , Jabbari, Reza , Lubitz, Steven A., Steinfurt, Johannes , Rudic, Boris , Shoemaker, Moore B., Weeke, Peter , Davies, Brianna , Andorin, Antoine , Hofman, Nynke , Pedrazzini, Matteo , Tester, David J. , Bos, J. Martijn , Platonov, Pyotr G. , Stallmeyer, Birgit, Zumhagen, Sven, Nannenberg, Eline A., Veldink, Jan H., Berg, Leonard H. van den, Al‐Chalabi, Ammar , Shaw, Christopher E. , Shaw, Pamela J. , Morrison, Karen , Müller‐Nurasyid, Martina , Cusi, Daniele , Lathrop, Mark , Munter, Markus, Aung, Tin , Ozaki, Mineo , Lichtner, Peter , Tintelen, J. Peter van , Hoedemaekers, Yvonne M., Napolitano, Carlo , Gourraud, Jean‐Baptiste , Makiyama, Takeru , Ohno, Seiko , Itoh, Hideki , Roden, Dan M. , Saenen, Johan , Borggrefe, Martin, Odening, Katja E. , Ellinor, Patrick T., Tfelt‐Hansen, Jacob , Skinner, Jonathan R. , Berg, Maarten P. van den , Makita, Naomasa , Breckpot, Jeroen , Yoshinaga, Masao , Behr, Elijah R. , Rydberg, Annika , Aiba, Takeshi , Priori, Silvia G. , Newton‐Cheh, Christopher , Schulze‐Bahr, Eric , Horie, Minoru , Wilde, Arthur A.M. , Tanck, Michael W.T. , Bezzina, Connie R. , Lubitz, Steven A. , Crotti, Lia , Makita, Naomasa , Horie, Minoru , Behr, Elijah Raphael , van Tintelen, J Peter , Odening, Katja E , Bos, Johan M , Tanck, Michael , Barc, Julien , Tfelt-Hansen, Jacob , Skinner, Jonathan R , van den Berg, Maarten P , Robyns, Tomas , Lubitz, Steven A , Al-Chalabi, Ammar , Bezzina, Connie R , Gourraud, Jean-Baptiste , Mazzanti, Andrea , Postema, Pieter G , Priori, Silvia , Walsh, Roddy , Tadros, Rafik , Beckmann, Britt-Maria, Shimamoto, Keiko , Wijeyeratne, Yanushi D. , Ishikawa, Taisuke , Arbelo, Elena , Christiansen, Michael , Loeys, Bart , Pfeiffer, Ryan D. , Dagradi, Federica , Sarquella-Brugada, Georgia , Campuzano, Óscar , Berg, Leonard H. van den , Andersen, Peter Munch , Barlassina, Cristina , Galán, Pilar , Werge, Thomas Mears , Ribasés, Marta , Khor, Chiea Chuen , Meitinger, Thomas , Denjoy, Isabelle , Leenhardt, Antoine , Shimizu, Wataru , Schott, Jean‐Jacques , Ohno, Seiko , Krahn, Andrew D. , Antzelevitch, Charles , Roden, Dan M. , Ellinor, Patrick T. , Olesen, Morten S. , Brugada, Josép , Brugada, Ramón , Aiba, Takeshi , Kääb, Stefan , Guicheney, Pascale , Tan, Hanno L. , Ackerman, Michael , Schwartz, Peter J. , Probst, Vincent

Mayo Clinic

Circulation | May 20, 2020 | Volume: 142 | Issue: 4 | Pages: 324-338

10.1161/circulationaha.120.045956 | PMID 32429735 Get It

Background: Long QT syndrome (LQTS) is a rare genetic disorder and a major preventable cause of sudden cardiac death in the young. A causal rare genetic variant with large effect size is identified in up to 80% of probands (genotype positive) and cascade family screening shows incomplete penetrance of genetic variants. Furthermore, a proportion of cases meeting diagnostic criteria for LQTS remain genetically elusive despite genetic testing of established genes (genotype negative). These observations raise the possibility that common genetic variants with small effect size contribute to the clinical picture of LQTS. This study aimed to characterize and quantify the contribution of common genetic variation to LQTS disease susceptibility. Methods: We conducted genome-wide association studies followed by transethnic meta-analysis in 1656 unrelated patients with LQTS of European or Japanese ancestry and 9890 controls to identify susceptibility single nucleotide polymorphisms. We estimated the common variant heritability of LQTS and tested the genetic correlation between LQTS susceptibility and other cardiac traits. Furthermore, we tested the aggregate effect of the 68 single nucleotide polymorphisms previously associated with the QT-interval in the general population using a polygenic risk score. Results: Genome-wide association analysis identified 3 loci associated with LQTS at genome-wide statistical significance ( P <5×10 −8 ) near NOS1AP , KCNQ1 , and KLF12 , and 1 missense variant in KCNE1 (p.Asp85Asn) at the suggestive threshold ( P <10 −6 ). Heritability analyses showed that ≈15% of variance in overall LQTS susceptibility was attributable to common genetic variation ( h2SNP 0.148; standard error 0.019). LQTS susceptibility showed a strong genome-wide genetic correlation with the QT-interval in the general population (r g =0.40; P =3.2×10 −3 ). The polygenic risk score comprising common variants previously associated with the QT-interval in the general population was greater in LQTS cases compared with controls ( P <10−13), and it is notable that, among patients with LQTS, this polygenic risk score was greater in patients who were genotype negative compared with those who were genotype positive ( P <0.005). Conclusions: This work establishes an important role for common genetic variation in susceptibility to LQTS. We demonstrate overlap between genetic control of the QT-interval in the general population and genetic factors contributing to LQTS susceptibility. Using polygenic risk score analyses aggregating common genetic variants that modulate the QT-interval in the general population, we provide evidence for a polygenic architecture in genotype negative LQTS.
A New Horizon in Neuromodulation
Hagedorn, Jonathan M. , Jameson, Jessica , Hagedorn, Jonathan M , Deer, Timothy R. , Mekhail, Nagy

Mayo Clinic

Pain Medicine | May 19, 2020 | Volume: 22 | Issue: 4 | Pages: 1012-1014

10.1093/pm/pnaa197 | PMID 32594131 Get It

Proclaim™ DRG Neurostimulator System for the Management of Chronic, Intractable Pain
Hagedorn, Jonathan M. , Demian, Pavli S., Scarfo, Keith-Austin, Engle, Alyson M. , Hagedorn, Jonathan M , Deer, Timothy R.

Mayo Clinic

Pain Management | May 19, 2020 | Volume: 10 | Issue: 4 | Pages: 225-233

10.2217/pmt-2020-0010 | PMID 32423306 Get It

Place, poverty and prescriptions: a cross-sectional study using Area Deprivation Index to assess opioid use and drug-poisoning mortality in the USA from 2012 to 2017
Kurani, Shaheen , McCoy, Rozalina G. , Inselman, Jonathan , Jeffery, Molly M. , Giblon, Rachel , Shah, Nilay D. , McCoy, Rozalina Grubina , Jeffery, Molly Moore, Jeffery, Molly Moore , Chawla, Sagar , Rutten, Lila J. Finney

Mayo Clinic

BMJ Open | May 18, 2020 | Volume: 10 | Issue: 5 | Pages: e035376

10.1136/bmjopen-2019-035376 | PMID 32423933 Get It

Objective To identify the relationships between county-level area deprivation and patterns of both opioid prescriptions and drug-poisoning mortality. Design, setting and participants For this retrospective cross-sectional study, we used the IQVIA Xponent data to capture opioid prescriptions and Centres for Disease Control and Prevention National Vital Statistics System to assess drug-poisoning mortality. The Area Deprivation Index (ADI) is a composite measure of social determinants of health comprised of 17 US census indicators, spanning four socioeconomic domains. For all US counties with available opioid prescription (2712 counties) and drug-poisoning mortality (3133 counties) data between 2012 and 2017, we used negative binomial regression to examine the association between quintiles of county-level ADI and the rates of opioid prescriptions and drug-poisoning mortality adjusted for year, age, race and sex. Primary outcome measures County-level opioid prescription fills and drug-poisoning mortality. Results Between 2012 and 2017, overall rates of opioid prescriptions decreased from 96.6 to 72.2 per 100 people, while the rates of drug-poisoning mortality increased from 14.3 to 22.8 per 100 000 people. Opioid prescription and drug-poisoning mortality rates were consistently higher with greater levels of deprivation. The risk of filling an opioid prescription was 72% higher, and the risk of drug-poisoning mortality was 36% higher, for most deprived compared with the least deprived counties (both p<0.001). Discussion Counties with greater area-level deprivation have higher rates of filled opioid prescriptions and drug-poisoning mortality. Although opioid prescription rates declined across all ADI quintiles, the rates of drug-poisoning mortality continued to rise proportionately in each ADI quintile. This underscores the need for individualised and targeted interventions that consider the deprivation of communities where people live.
Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice
Sherwood, Matthew W. , Piccini, Jonathan P. , Holmes, DaJuanicia N. , Pieper, Karen S. , Kowey, Peter R. , Mahaffey, Kenneth W. , Singer, Daniel E. , Ansell, Jack , Reiffel, James A. , Blanco, Rosalia , Steinberg, Benjamin A. , Fonarow, Gregg C. , Allen, Larry A. , Naccarelli, Gerald V. , Gersh, Bernard J. , Freeman, James V. , Chan, Paul S. , Peterson, Eric D. , Rao, Sunil V.

Mayo Clinic

Circulation: Cardiovascular Interventions | May 15, 2020 | Volume: 13 | Issue: 5 | Pages: No page available

10.1161/circinterventions.119.008274 | PMID 32408815 Get It

Background: Patients with atrial fibrillation on oral anticoagulation (OAC) undergoing cardiac catheterization face risks for embolic and bleeding events, yet information on strategies to mitigate these risks in contemporary practice is lacking. Methods: We aimed to describe the clinical/procedural characteristics of a contemporary cohort of patients with atrial fibrillation on OAC who underwent cardiac catheterization. Use of bleeding avoidance strategies and bridging therapy were described and outcomes including death, stroke, and major bleeding at 30 days and 1 year were compared by OAC type. Results: Of 13 404 patients in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II Registry from 2013 to 2016, 741 underwent cardiac catheterization (139 with percutaneous coronary intervention) in the setting of OAC. The patients’ median age was 71, 61.8% were male, white (87.2%), had hypertension (83.7%), hyperlipidemia (72.1%), diabetes mellitus (31.6%), and chronic kidney disease (28.2%); 20.2% received warfarin while 79.8% received direct acting oral anticoagulant. One third of patients underwent radial artery access, and bivalirudin was used in 4.6%. Bridging therapy was used more often in patients on warfarin versus direct acting oral anticoagulant (16.7% versus10.0%). OAC was interrupted in 93.8% of patients. Patients on warfarin versus direct acting oral anticoagulant were equally likely to restart OAC (58.0% versus 60.7%), had similar use of antiplatelet therapy (44.0% versus 41.3%) after catheterization, and had similar rates of myocardial infarction and death at 1 year, but higher rates of major bleeding (43.3 versus 12.9 events/100 patient years) and stroke (4.9 versus 1.9 events/100 patient years). Conclusions: In a real-world registry of patients with atrial fibrillation undergoing cardiac catheterization, most cases are elective, performed by femoral access, with interruption of OAC. Bleeding avoidance strategies such as radial artery access and bivalirudin were used infrequently and use of bridging therapy was uncommon. Nearly 40% of patients did not restart OAC postprocedure, exposing patients to risk for stroke. Further research is necessary to optimize the management of patients with atrial fibrillation undergoing cardiac catheterization.
Bronchial Rheoplasty for Treatment of Chronic Bronchitis. Twelve-Month Results from a Multicenter Clinical Trial
Valipour, Arschang , Fernández-Bussy, Sebastián , Ing, Alvin , Steinfort, Daniel , Snell, Gregory I. , Williamson, Jonathan , Saghaie, Tajalli , Irving, Louis, Dabscheck, Eli , Krimsky, William , Waldstreicher, Jonathan

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 14, 2020 | Volume: 202 | Issue: 5 | Pages: 681-689

10.1164/rccm.201908-1546oc | PMID 32407638 Get It

Abstract Rationale Chronic bronchitis (CB) is characterized by productive cough with excessive mucus production, resulting in quality-of-life impairment and increased exacerbation risk. Bronchial rheoplasty uses an endobronchial catheter to apply nonthermal pulsed electrical fields to the airways. Preclinical studies have demonstrated epithelial ablation followed by regeneration of normalized epithelium. Objectives To evaluate the feasibility, safety, and initial outcomes of bronchial rheoplasty in patients with CB. Methods Pooled analysis of two separate studies enrolling 30 patients undergoing bilateral bronchial rheoplasty was conducted. Follow-up through 6 months (primary outcome) and 12 months included assessment of adverse events, airway histology, and changes in symptoms using the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test and St. George’s Respiratory Questionnaire (SGRQ). Measurements and Main Results: Bronchial rheoplasty was performed in all 30 patients (63% male; mean [SD] age, 67 [7.4]; mean [SD] postbronchodilator FEV1, 65% [21%]; mean [SD] COPD Assessment Test score 25.6 [7.1]; mean [SD] SGRQ score, 59.6 [15.3]). There were no device-related and four procedure-related serious adverse events through 6 months, and there were none thereafter through 12 months. The most frequent nonserious, device- and/or procedure-related event through 6 months was mild hemoptysis in 47% (14 of 30) patients. Histologically, the mean goblet cell hyperplasia score was reduced by a statistically significant amount (P &lt; 0.001). Significant changes from baseline to 6 months in COPD Assessment Test (mean, −7.9; median, −8.0; P = 0.0002) and SGRQ (mean, −14.6; median, −7.2; P = 0.0002) scores were observed, with similar observations through 12 months. Conclusions This study provides the first clinical evidence of the feasibility, safety, and initial outcomes of bronchial rheoplasty in symptomatic patients with CB. Clinical trial registered with www.anzctr.org.au (ACTRN 12617000330347) and clinicaltrials.gov (NCT 03107494).
Desmoplastic Fibroblastoma: An Uncommon Tumor With a Relatively Characteristic MRI Appearance
Kresse, Maxine E. , Fox, Michael G. , Long, Jeremiah R. , Murphey, Mark D. , Kransdorf, Mark J. , Flug, Jonathan A.

Mayo Clinic

American Journal of Roentgenology | May 14, 2020 | Volume: 215 | Issue: 1 | Pages: 178-183

10.2214/ajr.19.22163 | PMID 32406775 Get It

Development of novel machine learning model for right ventricular quantification on echocardiography—A multimodality validation study
Beecy, Ashley , Bratt, Alex , Yum, Brian, Sultana, Razia , Das, Mukund, Sherifi, Ines, Devereux, Richard B. , Weinsaft, Jonathan W. , Kim, Jiwon , Bratt, Alex

Mayo Clinic

Echocardiography | May 12, 2020 | Volume: 37 | Issue: 5 | Pages: 688-697

10.1111/echo.14674 | PMID 32396705 Get It

Abstract Purpose Echocardiography (echo) is widely used for right ventricular (RV) assessment. Current techniques for RV evaluation require additional imaging and manual analysis; machine learning (ML) approaches have the potential to provide efficient, fully automated quantification of RV function. Methods An automated ML model was developed to track the tricuspid annulus on echo using a convolutional neural network approach. The model was trained using 7791 image frames, and automated linear and circumferential indices quantifying annular displacement were generated. Automated indices were compared to an independent reference of cardiac magnetic resonance (CMR) defined RV dysfunction (RVEF < 50%). Results A total of 101 patients prospectively underwent echo and CMR: Fully automated annular tracking was uniformly successful; analyses entailed minimal processing time (<1 second for all) and no user editing. Findings demonstrate all automated annular shortening indices to be lower among patients with CMR‐quantified RV dysfunction (all P < .001). Magnitude of ML annular displacement decreased stepwise in relation to population‐based tertiles of TAPSE, with similar results when ML analyses were localized to the septal or lateral annulus (all P ≤ .001). Automated segmentation techniques provided good diagnostic performance (AUC 0.69–0.73) in relation to CMR reference and compared to conventional RV indices (TAPSE and S ′) with high negative predictive value (NPV 84%–87% vs 83%–88%). Reproducibility was higher for ML algorithm as compared to manual segmentation with zero inter‐ and intra‐observer variability and ICC 1.0 (manual ICC: 0.87–0.91). Conclusions This study provides an initial validation of a deep learning system for RV assessment using automated tracking of the tricuspid annulus.
Open versus minimally invasive decompression for low-grade spondylolisthesis: analysis from the Quality Outcomes Database
Bisson, Erica F. , Mummaneni, Praveen V. , Virk, Michael S. , Knightly, John J. , Alvi, Mohammed Ali , Chan, Andrew K. , Glassman, Steven D. , Foley, Kevin T. , Slotkin, Jonathan R., Potts, Eric A. , Shaffrey, Mark E., Shaffrey, Christopher I. , Haid, Regis W., Fu, Kai-Ming, Wang, Michael Y. , Park, Paul , Asher, Anthony L. , Bydon, Mohamad , Alvi, Mohammed Ali , Goyal, Anshit , Guan, Jian

Mayo Clinic

Journal of Neurosurgery: Spine | May 8, 2020 | Volume: 33 | Issue: 3 | Pages: 349-359

10.3171/2020.3.spine191239 | PMID 32384269 Get It

OBJECTIVELumbar decompression without arthrodesis remains a potential treatment option for cases of low-grade spondylolisthesis (i.e., Meyerding grade I). Minimally invasive surgery (MIS) techniques have recently been increasingly used because of their touted benefits including lower operating time, blood loss, and length of stay. Herein, the authors analyzed patients enrolled in a national surgical registry and compared the baseline characteristics and postoperative clinical and patient-reported outcomes (PROs) between patients undergoing open versus MIS lumbar decompression.METHODSThe authors queried the Quality Outcomes Database for patients with grade I lumbar degenerative spondylolisthesis undergoing a surgical intervention between July 2014 and June 2016. Among more than 200 participating sites, the 12 with the highest enrollment of patients into the lumbar spine module came together to initiate a focused project to assess the impact of fusion on PROs in patients undergoing surgery for grade I lumbar spondylolisthesis. For the current study, only patients in this cohort from the 12 highest-enrolling sites who underwent a decompression alone were evaluated and classified as open or MIS (tubular decompression). Outcomes of interest included PROs at 2 years; perioperative outcomes such as blood loss and complications; and postoperative outcomes such as length of stay, discharge disposition, and reoperations.RESULTSA total of 140 patients undergoing decompression were selected, of whom 71 (50.7%) underwent MIS and 69 (49.3%) underwent an open decompression. On univariate analysis, the authors observed no significant differences between the 2 groups in terms of PROs at 2-year follow-up, including back pain, leg pain, Oswestry Disability Index score, EQ-5D score, and patient satisfaction. On multivariable analysis, compared to MIS, open decompression was associated with higher satisfaction (OR 7.5, 95% CI 2.41–23.2, p = 0.0005). Patients undergoing MIS decompression had a significantly shorter length of stay compared to the open group (0.68 days [SD 1.18] vs 1.83 days [SD 1.618], p < 0.001).CONCLUSIONSIn this multiinstitutional prospective study, the authors found comparable PROs as well as clinical outcomes at 2 years between groups of patients undergoing open or MIS decompression for low-grade spondylolisthesis.
Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Saad, Ayman , Anand, Sarah , Bookout, Ryan, Couriel, Daniel R. , Stasi, Antonio Di , El‐Jawahri, Areej , Gutman, Jonathan A. , Ho, Vincent T. , Horwitz, Mitchell E. , Hsu, Joe L. , Dabaja, Mohamed Kharfan, Loren, Alison W. , MSCE, Meade, Javier Bolaños, Moreira, Jonathan , Nakamura, Ryotaro , Roddy, Julianna, Satyanarayana, Gowri, Tan, Carlyn , Tzachanis, Dimitrios , Burns, Jennifer L. , Pluchino, Lenora A. , Saad, Ayman , Lima, Marcos de , Bhatt, Vijaya Raj , Chen, George T , Giralt, Sergio , Juckett, Mark , MSCE, Mielcarek, Marco B. , Nieto, Yago , Schroeder, Mark A.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | May 7, 2020 | Volume: 18 | Issue: 5 | Pages: 599-634

10.6004/jnccn.2020.0021 | PMID 32519831 Get It

Hematopoietic cell transplantation (HCT) involves the infusion of hematopoietic progenitor cells into patients with hematologic disorders with the goal of re-establishing normal hematopoietic and immune function. HCT is classified as autologous or allogeneic based on the origin of hematopoietic cells. Autologous HCT uses the patient’s own cells while allogeneic HCT uses hematopoietic cells from a human leukocyte antigen-compatible donor. Allogeneic HCT is a potentially curative treatment option for patients with certain types of hematologic malignancies, and autologous HCT is primarily used to support patients undergoing high-dose chemotherapy. Advances in HCT methods and supportive care in recent decades have led to improved survival after HCT; however, disease relapse and posttransplant complications still commonly occur in both autologous and allogeneic HCT recipients. Allogeneic HCT recipients may also develop acute and/or chronic graft-versus-host disease (GVHD), which results in immune-mediated cellular injury of several organs. The NCCN Guidelines for Hematopoietic Cell Transplantation focus on recommendations for pretransplant recipient evaluation and the management of GVHD in adult patients with malignant disease.